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Primary intestinal lymphangiectasia is a rare disorder characterized by severe protein-losing enteropathy
resulting in lymphopenia, hypoalbuminemia, and hypogammaglobulinemia. It may be associated with
limb lymphedema, chylous ascites, and abdominal lymphatic malformations.
We describe a 20 year-old female with progressive primary intestinal lymphangiectasia, severe
bilateral lower extremity lymphedema and a massive abdominal and retroperitoneal lymphatic mal-
formation who developed debilitating symptoms and protein/calorie malnutrition. Our treatment
approach included multidisciplinary management and eventual surgical debulking resection.
Although the management of primary intestinal lymphangiectasia is usually medical, in the rare case
of primary intestinal lymphangiectasia with associated chylous ascites and extensive abdominal
lymphatic malformation, surgical resection appears to be a safe and successful strategy to improve
nutrition and quality of life. As in the present case, complex and severe vascular anomalies necessitate a
combined treatment approach, which is available at multidisciplinary vascular anomalies centers.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Primary intestinal lymphangiectasia (PIL) is an uncommon
chronic debilitating disease characterized by a severe protein-
losing enteropathy leading to lymphopenia, hypoalbuminemia, and
hypogammaglobulinemia. It may be associated with lower limb
lymphedema, chylous ascites, and abdominal lymphatic malfor-
mation (LM). The management is usually medical, with lifelong
low-fat diet and supplemental medium-chain triglycerides (MCTs)
as the mainstay of treatment [1e3]. Although patients with local-
ized PIL have had some success with segmental bowel resections
[4,5], exceptional cases with associated massive abdominal and
retroperitoneal LMs may require an aggressive surgical approach.
We describe a unique case demonstrating not only the ability to
safely surgically resect the diffuse and multiloculated intra-
abdominal LM, but also clinical success with this technique as
evidenced by the patient’s improved nutritional and respiratory
status postoperatively.þ1 323 361 3534.
lmo).
Inc. Open access under CC BY-NC-ND licen1. Case report
A 20 year-old female was referred to our vascular anomalies
center (VAC) for management of worsening bilateral lower ex-
tremity (BLE) lymphedema and intractable massive ascites. Her
congenital BLE lymphedema had been previously fairly controlled
with compression garments. At age 10, she was hospitalized for
over one month for acute respiratory distress syndrome due to
varicella infection requiring high frequency oscillatory ventilation.
Approximately 8 months after this hospitalization she began to
develop “loculated ascites” which progressively worsened over the
next 10 years. Her ascites was initially treated successfully with
intravenous albumin and diuretics; however, this gradually lost
effectiveness and she eventually required serial paracenteses.
When her abdominal LM and chylous ascites ultimately became
intractable to medical therapy, the patient sought additional care.
Of note, her family history was negative for lymphatic disorders or
vascular anomalies.
At presentation to our center, she weighed 120 kg but appeared
cachectic with temporal and upper extremity wasting and
malnourished with a massive abdominal girth (156 cm) and severe
BLE lymphedema (Fig. 1A and B). She was non-ambulatory and
unable to lay supine, requiring bilevel positive airway pressure
(BiPAP) to sleep. The patient was admitted to the hospital andse.
Fig. 1. A) Preoperatively the patient weighed 120 kg but appeared cachectic and malnourished. She had massive abdominal girth (156 cm) and severe bilateral lower extremity
lymphedema. B) Preoperative lateral view. C) Two months postoperatively the patient’s weight and abdominal girth had decreased signiﬁcantly, but her cachexia and malnutrition
persisted. D) Six months postoperatively she was maintaining her postoperative weight, and her cachexia and nutritional status had much improved.
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including pediatrics, pulmonary, hematology, gastroenterology,
plastic and general surgery. She was found to have restrictive lung
disease secondary to massive ascites requiring oxygen, BiPAP, di-
uretics and intermittent paracenteses (Fig. 2A and B). Endoscopy
with duodenal biopsy demonstrated mucosa with dilated
lymphatic channels ﬁlled with proteinaceous ﬂuid and occasional
lymphocytes consistent with intestinal lymphangiectasia. Her he-
matologic and clinical chemistry testing was consistent with
1) anemia of chronic disease (hemoglobin 10.5 g/dL, MCV 70.6 fL, Fe
16mcg/dL, Ferritin 292 ng/mL, TIBC 128mcg/dL and Iron % Sat 12%),
2) thrombocytosis (1048 K/uL) likely secondary to chronic inﬂam-
mation (C-reactive protein 26.1 mg/dL), 3) lymphopenia (lympho-
cytes 2%), and 4) hypoalbuminemia (2.4 g/dL on admission with a
preoperative nadir of 1.9 g/dL secondary to intestinal lym-
phangiectasia). Interestingly, she did not demonstrate hypogam-
maglobulinemia (IgG 1550 mg/dL was elevated and both IgM
106 mg/dL and IgA 163 mg/dL were normal). The patient’s fecal
alpha-1-antitrypsin level (10.8 mg/g dry stool) was consistent with
protein-losing enteropathy, which was managed by an extremely
low fat elemental enteral diet and parenteral nutrition. Her pre-
operative management goal was medical optimization with
particular attention to her nutritional and respiratory status. Her
prealbumin improved from only <1.2 to 5.5 mg/dL preoperatively.
After a 1-month hospitalization, she was taken to the operating
room for an exploratory laparotomy with extensive lysis of adhe-
sions, as well as systematic drainage, unrooﬁng, and subtotal exci-
sion of numerous multiloculated LMs from the peritoneal cavity,
mesentery, and retroperitoneum (Fig. 3A). Asmuch of the LMswere
removed as possible taking care to avoid injury to the bowel, retro-
peritoneal structures such as the iliac vessels and ureters, as well as
intra-abdominal viscera such as the gallbladder, spleen and liver. No
bowel was excised as her PIL was diffuse. The limits of debulking
included the border of nearlyevery visceral and vascular structure in
the abdomen and retroperitoneum. Thirty-ﬁve liters of ascites and
lymphatic ﬂuid were drained, ﬁbrin sealant was applied to all sur-
faces, and four 15 French Blake drains were placed, one in each
quadrant. Additionally, she underwent open Stamm gastrostomy
tube placement. The operative time was 18 h. The histopathology
was consistent with extensive lymphangiectasia and lymphatic
malformation without evidence of malignancy (Fig. 3BeC).
She was discharged to home 1 month after her operation off
parental nutrition on a low-fat diet with elemental formula sup-
plementation. She was able to ambulate and sleep supine withoutBiPAP. Her hematologic and clinical chemistry testing at discharge
was consistent with 1) continued anemia of chronic disease (he-
moglobin 9.7 g/dL, Fe 25 mcg/dL, Ferritin 357 ng/mL, TIBC 118 mcg/
dL and Iron % Sat 21%), 2) improving thrombocytosis (833 K/uL)
likely secondary to chronic inﬂammation, which was also
improving (C-reactive protein 7.5 mg/dL), 3) continued lympho-
penia (lymphocytes 1%), and 4) slightly improving hypo-
albuminemia (2.6 g/dL). Her prealbumin improved to 8.2 at
discharge. Her weight was 113.9 kg preoperatively and 97.5 kg
immediately postoperatively. At discharge, she weighed 88 kg and
has maintained this weight at two (85.5 kg) and six months (89 kg)
postoperatively (Fig. 1C and D). Her abdominal girth was 155.5 cm
preoperatively and 129 cm at discharge. Her gastrostomy was
removed 6 months postoperatively and she maintains a low-fat
diet. She is currently doing well at 4 years after operation with no
signiﬁcant recurrence of the intra-abdominal LM.
2. Discussion
Primary intestinal lymphangiectasia (Waldmann’s disease) was
ﬁrst described by Waldmann et al. in 1961 in a case series of 18
patients with “idiopathic hypercatabolic hypoproteinemia” [6]. The
most common clinical sign is limb lymphedema, which is usually
symmetrical and located in the lower extremities [1,2]. Our pa-
tient’s clinical presentation was consistent with this as she had BLE
lymphedema from birth. Hallmark biochemical characteristics
include: lymphopenia, hypoalbuminemia, and hypogammaglobu-
linemia [1e3], as well as protein-losing enteropathy conﬁrmed by
high stool alpha-1-antitrypsin clearance due to enteric protein loss
[1,7], although the sensitivity of this test has been debated and may
be as low as 58% [8]. Our patient demonstrated all of these typical
ﬁndings except for hypogammaglobulinemia. The diagnosis of PIL is
conﬁrmed by endoscopy (upper endoscopy and videocapsule
endoscopy) with macroscopic ﬁndings of dilated intestinal lacteals
and microscopic features including presence of lacteal juice as well
as dilated mucosal and submucosal lymphatics [1e3]. Endoscopy at
both 10 and 20 years of age conﬁrmed these ﬁndings in our patient.
Non-dietary treatments of PIL have been suggested including
antiplasmin, octreotide, corticosteroids, albumin infusion and sur-
gery but their success has been unpredictable [1e3]. Although
octreotidemay help tomaintain serum albumin levels and decrease
the need for albumin infusions, results were variable among a small
number of patients [9]. Albumin infusion appears to only tran-
siently relieve symptoms [1]. Small bowel resection for PIL can be
Fig. 2. A) Chest radiograph demonstrating the patient’s restrictive lung disease sec-
ondary to massive ascites and intraabdominal lymphatic malformations. B) Computed
tomography scan reveals the patient’s massive ascites and numerous intraabdominal
multiloculated lymphatic malformations.
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cation in diffuse PIL [4,5]. Our patient received numerous albumin
infusions with some beneﬁt, but she did not receive antiplasmin,
octreotide, corticosteroids, nor was a small bowel resection indi-
cated, given her diffuse PIL.Fig. 3. A) Intraoperative photo revealing the extent of the intraabdominal lymphatic ma
peritoneum. B) H&E micrograph (20) demonstrating a lymphatic malformation cyst wal
organized ﬁbrinous material with presence of foamy macrophages. Additionally, acute conge
foci of inﬁltration of lymphocytes and plasma cells, as well as adipose tissue.In patients with PIL, extraintestinal lymphatic involvement may
lead to associated chylous ascites and intra-abdominal LMs [1,2].
Intra-abdominal LMs occurring in the omentum, mesentery, and
retroperitoneum are much less common than the classic head and
neck region [10]. While the mainstay of treatment of PIL is lifelong
diet modiﬁcation with low-fat diet and MCT supplementation [1e3],
these associated conditions may require other interventions to
improve quality of life. Paracentesis has variable effectiveness for
chylous ascites as was the case with our patient [2]. Sclerotherapy
with picibanil (OK-432), doxycycline, ethanol, or bleomycin has
shown promising success for the treatment of LMs, especially for
easily accessible single macrocystic LMs in the head and neck
[2,10e13]. Although, Chaudry et al. suggest that percutaneous image-
guided sclerotherapy of macrocystic intra-abdominal LMs with
doxycycline is a safe and effective alternative to surgical resection,
which has been the traditional approach [11]. Our patient did not
undergo sclerotherapy, as her intra-abdominal LMs were too exten-
sive,massive, andmultiloculated. Additionally, the 35 L of ascites and
lymphatic ﬂuid that was drained from our patient intraoperatively
would not have been amenable to percutaneous sclerotherapy.
Although surgical excision of intra-abdominal LMs is generally
considered to be more effective than sclerotherapy, there is still a
high recurrence rate [10,12]. Furthermore, complete surgical exci-
sion of intra-abdominal LMs is infrequently possible due to their
diffuse nature and extensive involvement of neurovascular struc-
tures [10,12e14]. Since LMs are benign malformations, it is rec-
ommended to accept an incomplete excisionwith a recurrence rate
rather than to sacriﬁce vital organs or neurovascular structures
[10,12,14]. The few that have reported success with complete sur-
gical excision of intra-abdominal LMs describe resection of a single
macrocystic LM rather than numerous, diffuse, multiloculated LMs
[15]. Our patient is an example of the latter. Even though numerous
mesenteric and retroperitoneal LMs were removed, the goal of her
operation was not a curative excision, but rather a palliative pro-
cedure to improve quality of life and ameliorate life-threatening
symptoms such as restrictive lung disease and severe malnutrition.
Although no randomized controlled trials exist conﬁrming
improvement in clinical outcomes, several authors have cited the
importance of multidisciplinary care for children with vascular
anomalies [2,13,16]. We believe that the clinical success with this
unique patient was due to her multidisciplinary care at our vascular
anomalies center.3. Conclusion
Primary intestinal lymphangiectasia with chylous ascites and
intra-abdominal lymphatic malformation is a chronic debilitating
disorder that may lead to severe and even life-threatening compli-
cations. Although most patients are often managed conservativelylformations involving every visceral and vascular surface in the abdomen and retro-
l partially lined by endothelial cells and attached to the inner cyst surface a partially
stion and hemorrhage is seen throughout. C) H&E micrograph (100) showing scattered
A.L. Speer et al. / J Ped Surg Case Reports 1 (2013) 425e428428with diet modiﬁcation and medical therapy, extensive abdominal
disease with extraintestinal involvement mandates a more compre-
hensive approach engaging multiple disciplines and on occasion,
primary surgical debulking.
Consent
Written informed consent was obtained from the patient for
publication of this case report and accompanying images. A copy of
the written consent is available for review by the Editor-in-Chief of
this journal on request.References
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